Another study also demonstrated that the SCD inhibitor CVT-11127 inhibits SCD activity in human lung cancer cells, inhibiting cancer cell proliferation by blocking cell cycle progression and triggering programmed cell death [197]. This evidence concerns the gene SCD and lung carcinoma.